×
For best experience we recommend to activate Javascript in your browser.
ABL1 antibody (AA 231-260)
The Rabbit Polyclonal anti-ABL1 antibody has been validated for WB and ELISA. It is suitable to detect ABL1 in samples from Human.
Quick Overview for ABL1 antibody (AA 231-260) (ABIN3030215)
Target
See all ABL1 Antibodies
ABL1
(C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
Reactivity
All reactivities for ABL1 antibodies
Human
Host
All hosts for ABL1 antibodies
Rabbit
Clonality
All clonalities for ABL1 antibodies
Polyclonal
Conjugate
All conjugates for ABL1 antibodies
This ABL1 antibody is un-conjugated
Application
All applications for ABL1 antibodies
Western Blotting (WB), ELISA
Product Details anti-ABL1 Antibody
(hide)
Binding Specificity
All epitopes for ABL1 antibodies
AA 231-260
Cross-Reactivity (Details)
Expected species reactivity: Mouse
Purification
Antigen affinity purified
Immunogen
A portion of amino acids 231-260 from the human protein was used as the immunogen for this ABL1 antibody.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Titration of the ABL1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
In 1X PBS, pH 7.4, with 0.09 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot the ABL1 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Target Details for ABL1
(hide)
Target
ABL1
(C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
Alternative Name
ABL1
Background
The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9,22) translocation results in the head-to-tail fusion of the BCR and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1.
UniProt
P00519
Pathways
Apoptosis , Regulation of Muscle Cell Differentiation , Platelet-derived growth Factor Receptor Signaling , Lipid Metabolism
Recently viewed
(hide)
Chat with us , powered by LiveChat